CollabRx Announces Oncology-Specific Mobile App With Leading Site for Healthcare Professionals, MedPage Today

SAN FRANCISCO, Aug. 13, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a healthcare information technology company focused on informing clinical decision making in molecular medicine, today announced a multi-year agreement with Everyday Health's MedPage Today, the leading provider of real-time breaking medical news for healthcare professionals. A division of the leading digital health and wellness media company Everyday Health, MedPage Today reaches over one-third of all US physicians including 96% of all oncologists. The mobile application is scheduled for release later this year.

The forthcoming app, which will target oncologists and pathologists, will focus on the molecular aspects of laboratory testing and therapy development, the foundation of "precision" oncology in which each patient's cancer treatment plan is individually tailored to reflect the genetic profile of their tumor. Over time, the expectation is that this app will serve as a comprehensive point of care resource for physicians and patients to obtain highly credible, expert-vetted and dynamically updated information to guide cancer treatment planning.

CollabRx will provide decision support, expert systems and electronic reference tools using the company's proprietary technology, leveraging CollabRx's large and growing network of over 75 leading clinical practitioners in the U.S. and Europe. MedPage Today will develop the application, include its relevant medical news and promote the app to its audience.

"Our company is committed to providing the best web-based and mobile decision support tools to our audience," said Ben Wolin, CEO and Co-Founder Everyday Health, Inc. "CollabRx's platform provides access to medical and scientific advances in genomic medicine so MedPage Today physicians can access information on treatment options at the point of care."

"MedPage Today has become the fastest growing news source for healthcare professionals and it is one of the most innovative and entrepreneurial companies in the online media industry," said Thomas Mika, Chairman and CEO of CollabRx, Inc. "We could not have picked a better partner for our initial entry into the rapidly growing mobile healthcare market in which physicians are increasingly using smartphones and tablets at the point of care. This agreement opens up a new, primary channel to support both our near-term growth and our long-term strategy to build a knowledge franchise in molecular medicine for practicing physicians."

The agreement replaces and extends a previous agreement between CollabRx and MedPage Today in which a white labeled version of CollabRx's web-based Therapy Finder™ decision support tool is provided to physicians at as their Oncology Next diagnostic tool.

About CollabRx

CollabRx, Inc. (Nasdaq:CLRX) is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts, starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care. More information may be obtained at

About MedPage Today

MedPage Today is a leading medical news organization serving healthcare professionals. The company's daily, peer-reviewed news coverage delivered digitally allows healthcare professionals to put breaking medical news into practice. MedPage Today also offers coverage of health conferences from around the world in almost any specialty, providing physicians access to live video interviews and dialogues to encourage better health outcomes.

About Everyday Health, Inc.

Everyday Health is the leading digital health and wellness company. Attracting over 40 million people monthly through its popular websites, mobile applications, and social media presence, Everyday Health inspires consumers to live healthier lives and helps doctors make more informed decisions for their patients. Everyday Health reaches an additional one million viewers per episode through its weekly TV series. The Company's broad portfolio of products spans the health spectrum, from in-depth medical content for condition prevention and management to healthy lifestyle offerings. Everyday Health was founded in 2002 by CEO, Ben Wolin, and President, Mike Keriakos.

CollabRx Safe Harbor Statement

This press release includes forward-looking statements about CollabRx's anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and CollabRx's plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by CollabRx with the Securities and Exchange Commission. CollabRx undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

CONTACT: CollabRx Contacts: Gavin J. Gordon, MBA, PhD Vice President, Business Development & Strategic Alliances CollabRx, Inc. (415) 248-5350 or James Carbonara Hayden IR 646-755-7412 Everyday Health Contact: Jennifer Perciballi Vice President, Public Relations Everyday Health, Inc. (646) 728-9777 office (646) 476-1245 mobile

Source:CollabRx, Inc.